Compounds > protoporphyrin ix
Page last updated: 2024-08-16

protoporphyrin ix and methyl 5-aminolevulinate

protoporphyrin ix has been researched along with methyl 5-aminolevulinate in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (19.57)29.6817
2010's34 (73.91)24.3611
2020's3 (6.52)2.80

Authors

AuthorsStudies
Callan, JF; Jack, IG; Kavanagh, ON; Loan, P; McEwan, C; McHale, AP; McKenna, K; Nesbitt, H; Nicholas, D1
Iani, V; Juzenas, P; Juzeniene, A; Ma, LW; Moan, J1
Hong, SH; Kwon, YH; Lee, JB; Lee, SC; Won, Y; Yu, HY; Yun, SJ1
Campbell, S; Curnow, A; Pye, A1
Haedersdal, M; Togsverd-Bo, K; Wiegell, SR; Wulf, HC1
Enk, CD; Eriksen, P; Haedersdal, M; Philipsen, PA; Wiegell, SR; Wulf, HC1
de Bruijn, HS; Meijers, C; Robinson, DJ; Sterenborg, HJ; van der Ploeg-van den Heuvel, A1
Cicarma, E; Juzeniene, A; Ma, LW; Moan, J; Tuorkey, M1
Ferguson, J; Lesar, A; Moseley, H2
Bloznelyte-Plesniene, L; Liutkeviciūte-Navickiene, J; Mordas, A; Simkute, S1
Campbell, S; Curnow, A; Tyrrell, J1
Denk, K; Enk, A; Gholam, P; Hartmann, M; Sehr, T1
Campbell, SM; Curnow, A; Tyrrell, J1
Carrasco, E; Cogno, IS; Gilaberte, Y; Juarranz, A; Milla, LN; Rivarola, VA; Rodríguez, ME; Sanz-Rodríguez, F; Zamarrón, A1
Campbell, SM; Curnow, A; Morton, C; Tyrrell, JS1
Allan, D; Allan, E; Bayat, A; Colthurst, J; Sebastian, A1
Blázquez-Castro, A; Calvo, MI; Carrasco, E; Espada, J; Jaén, P; Juarranz, A; Sánz-Rodríguez, F; Stockert, JC1
Haedersdal, M; Lerche, CM; Philipsen, PA; Poulsen, T; Togsverd-Bo, K; Wulf, HC1
Baldursson, BT; Bäumler, W; Enk, CD; Fabricius, S; Heydenreich, J; Rosso, S; Wiegell, SR; Wulf, HC1
Allan, D; Allan, E; Alonso-Rasgado, T; Bayat, A; Mandal, P; Mendoza, J; Sebastian, A1
Hædersdal, M; Idorn, LW; Philipsen, PA; Togsverd-Bo, K; Wulf, HC1
Allen, J; Blake, E; Curnow, A; Shore, A; Thorn, C1
Allen, J; Blake, E; Campbell, S; Curnow, A; Helliwell, P; Mathew, J1
Barge, J; Kasraee, B; Piffaretti, F; Salomon, D; van den Bergh, H; Wagnières, G; Zellweger, M1
Petersen, B; Wiegell, SR; Wulf, HC2
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K; Wulf, HC1
Fabricius, S; Lerche, CM; Philipsen, PA; Wulf, HC1
Nissen, CV; Philipsen, PA; Wulf, HC1
Ibbotson, SH; Kulyk, O; Moseley, H; Samuel, ID; Valentine, RM1
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K1
Nissen, CV; Philipsen, PA; Wiegell, SR; Wulf, HC1
Christiansen, K; Erlendsson, AM; Haak, CS; Haedersdal, M; Taudorf, EH; Thaysen-Petersen, D; Wulf, HC1
Curnow, A; Dodd, NJF; Dogra, Y; Ferguson, DCJ; Smerdon, GR; Winyard, PG1
Heerfordt, IM; Mikkelsen, CS; Nissen, CV; Wiegell, SR; Wulf, HC1
Bowling, J; Campbell, S; Ibbotson, S; Kownacki, S; Morton, CA; Sivaramakrishnan, M; Stones, R; Valentine, R1
Bouvier, G; Comby, P; Gaborit, A; Hanaizi, J; Kouidhi, M; Osman-Ponchet, H; Ruty, B; Sevin, K1
Bay, C; Ferrick, B; Haedersdal, M; Lerche, CM; Philipsen, PA; Togsverd-Bo, K1
Bieliauskiene, G; Heerfordt, IM; Wulf, HC1
Barlier, C; Bezdetnaya, L; Dolivet, G; Francois, A; Leufflen, L; Marchal, F; Salleron, J1
Carrasco, E; Damian, A; Delgado-Wicke, P; Juarranz, Á; Lucena, SR; Mascaraque, M1
Wulf, HC1
Bagnato, VS; Moriyama, LT; Stringasci, MD; Vollet-Filho, JD1
Brebi, P; Buchegger, K; Ili, C; Kurachi, C; León, D; Mora-Lagos, B; Riquelme, I; Roa, JC; Schafer, F; Silva, R; Viscarra, T; Zanella, L1
Bagnato, VS; Buzza, HH; Ciol, H; Inada, NM; Leite, IS; Romano, RA; Stringasci, MD1

Trials

14 trial(s) available for protoporphyrin ix and methyl 5-aminolevulinate

ArticleYear
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:8

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Line, Tumor; Humans; In Vitro Techniques; Iron Chelating Agents; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Pyridones; Skin Neoplasms

2008
Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3

    Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Edema; Erythema; Female; Fluorescence; Humans; Laser Therapy; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Diseases; Treatment Outcome

2008
Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
    The British journal of dermatology, 2008, Volume: 158, Issue:4

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Drug; Facial Dermatoses; Female; Heliotherapy; Humans; Keratosis; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Single-Blind Method; Treatment Outcome

2008
A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Photodermatology, photoimmunology & photomedicine, 2009, Volume: 25, Issue:4

    Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Female; Fluorescence; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Time Factors

2009
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    The British journal of dermatology, 2011, Volume: 164, Issue:6

    Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Protoporphyrins; Scalp Dermatoses; Skin Neoplasms

2011
Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
    Lasers in medical science, 2013, Volume: 28, Issue:3

    Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Oxygen; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Pressure; Protoporphyrins; Skin Neoplasms

2013
The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
    Journal of photochemistry and photobiology. B, Biology, 2012, Dec-05, Volume: 117

    Topics: Aminolevulinic Acid; Biological Transport; Carcinoma, Basal Cell; Injections; Oxygen; Photosensitizing Agents; Pressure; Prodrugs; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Time Factors

2012
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
    The British journal of dermatology, 2014, Volume: 171, Issue:6

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome

2014
Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
    The British journal of dermatology, 2015, Volume: 173, Issue:3

    Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Aminolevulinic Acid; Drug Combinations; Female; Fluorescence; Humans; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Young Adult

2015
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
    Photodiagnosis and photodynamic therapy, 2015, Volume: 12, Issue:4

    Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Optical Imaging; Photosensitizing Agents; Point-of-Care Systems; Protoporphyrins; Skin Neoplasms

2015
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
    The British journal of dermatology, 2016, Volume: 174, Issue:5

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome

2016
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    The British journal of dermatology, 2017, Volume: 176, Issue:5

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Drug Eruptions; Erythema; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins

2017
Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
    JAMA dermatology, 2017, Apr-01, Volume: 153, Issue:4

    Topics: Adolescent; Adult; Aminolevulinic Acid; Curettage; Denmark; Dermabrasion; Female; Fluorescence; Humans; Laser Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Young Adult

2017
Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 22

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Scalp

2018

Other Studies

32 other study(ies) available for protoporphyrin ix and methyl 5-aminolevulinate

ArticleYear
Comparing the efficacy of photodynamic and sonodynamic therapy in non-melanoma and melanoma skin cancer.
    Bioorganic & medicinal chemistry, 2016, 07-01, Volume: 24, Issue:13

    Topics: Aminolevulinic Acid; Animals; Heterografts; Humans; Melanoma; Mice, SCID; Photochemotherapy; Skin Neoplasms; Ultrasonic Therapy

2016
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
    The British journal of dermatology, 2006, Volume: 155, Issue:4

    Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Humans; Middle Aged; Photosensitizing Agents; Protoporphyrins; Skin; Skin Absorption; Spectrometry, Fluorescence

2006
Photodetection of basal cell carcinoma using methyl 5-aminolaevulinate-induced protoporphyrin IX based on fluorescence image analysis.
    Clinical and experimental dermatology, 2007, Volume: 32, Issue:4

    Topics: Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Male; Middle Aged; Photosensitizing Agents; Protoporphyrins; Sensitivity and Specificity; Spectrometry, Fluorescence

2007
Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    Journal of photochemistry and photobiology. B, Biology, 2008, Aug-21, Volume: 92, Issue:2

    Topics: Administration, Topical; Aminolevulinic Acid; Animals; Mice; Microscopy, Fluorescence; Photosensitizing Agents; Protoporphyrins; Skin

2008
Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells.
    The British journal of dermatology, 2009, Volume: 161, Issue:2

    Topics: Aminolevulinic Acid; Calcitriol; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Tumor Stem Cell Assay

2009
[Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester].
    Medicina (Kaunas, Lithuania), 2009, Volume: 45, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Esters; Female; Fluorescence; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Photosensitizing Agents; Precancerous Conditions; Prognosis; Protoporphyrins; Sensitivity and Specificity; Skin; Skin Neoplasms

2009
Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
    Photodiagnosis and photodynamic therapy, 2010, Volume: 7, Issue:2

    Topics: Aged; Aminolevulinic Acid; Dose-Response Relationship, Drug; Fluorescence; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reproducibility of Results; Skin; Skin Neoplasms

2010
Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cosmetic Techniques; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Nerve Endings; Pain; Pain Measurement; Photochemotherapy; Protoporphyrins; Retrospective Studies; Sex Characteristics; Treatment Outcome

2010
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
    Photodiagnosis and photodynamic therapy, 2011, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Combinations; Female; Humans; Male; Metabolic Clearance Rate; Microscopy, Fluorescence; Middle Aged; Organ Specificity; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Treatment Outcome

2011
An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin.
    Photodiagnosis and photodynamic therapy, 2011, Volume: 8, Issue:2

    Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Back; Female; Fluorescence; Forearm; Humans; Leg; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin

2011
Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy.
    Journal of cellular biochemistry, 2011, Volume: 112, Issue:9

    Topics: Aminolevulinic Acid; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Nucleus Shape; Cell Shape; Cell Survival; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Neoplasms; Ubiquitin-Protein Ligases

2011
Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
    Journal of dermatological science, 2011, Volume: 64, Issue:3

    Topics: Adult; Aged; Aminolevulinic Acid; Apoptosis; Blotting, Western; Case-Control Studies; Caspase 3; Cell Proliferation; Cells, Cultured; Collagen Type I; Collagen Type III; Combined Modality Therapy; Electric Stimulation Therapy; Enzyme Activation; Female; Fibroblasts; Flow Cytometry; Gene Expression Regulation; Humans; Keloid; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase 2; Membrane Potential, Mitochondrial; Middle Aged; Necrosis; Photochemotherapy; Photosensitizing Agents; Polymerase Chain Reaction; Protoporphyrins; Reactive Oxygen Species; Time Factors

2011
Protoporphyrin IX-dependent photodynamic production of endogenous ROS stimulates cell proliferation.
    European journal of cell biology, 2012, Volume: 91, Issue:3

    Topics: Aminolevulinic Acid; Cell Cycle; Cell Proliferation; Humans; Keratinocytes; NADPH Oxidase 1; NADPH Oxidases; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; src-Family Kinases; Tumor Cells, Cultured

2012
Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
    Experimental dermatology, 2012, Volume: 21, Issue:4

    Topics: Administration, Topical; Aminolevulinic Acid; Animals; Biological Availability; Female; Humans; Mice; Mice, Hairless; Microscopy, Fluorescence; Models, Animal; Photochemotherapy; Photosensitizing Agents; Porphyrins; Precancerous Conditions; Protoporphyrins; Skin; Skin Neoplasms; Tissue Distribution; Ultraviolet Rays

2012
Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
    The British journal of dermatology, 2013, Volume: 168, Issue:1

    Topics: Aminolevulinic Acid; Dose-Response Relationship, Radiation; Europe; Geography, Medical; Humans; Israel; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Radiometry; Residence Characteristics; Seasons; Skin Neoplasms; Sunlight; Temperature; Ultraviolet Rays; Weather

2013
Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion.
    Archives of dermatological research, 2012, Volume: 304, Issue:7

    Topics: Adult; Aminolevulinic Acid; Apoptosis; Cell Differentiation; Cells, Cultured; Cellular Senescence; Female; Fibroblasts; Humans; Keloid; Male; Middle Aged; Photochemotherapy; Protoporphyrins; Reactive Oxygen Species; Skin

2012
Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
    Experimental dermatology, 2012, Volume: 21, Issue:10

    Topics: Adolescent; Adult; Aminolevulinic Acid; Dermis; Epidermis; Humans; Lasers, Dye; Light; Microscopy, Fluorescence; Middle Aged; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Young Adult

2012
Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.
    Dermatology (Basel, Switzerland), 2013, Volume: 227, Issue:3

    Topics: Aged; Aminolevulinic Acid; Fluorescence; Humans; Keratosis, Actinic; Middle Aged; Pain; Pain Measurement; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Treatment Outcome

2013
Calcipotriol pretreatment enhances methyl aminolevulinate-induced protoporphyrin IX: an in vivo study in hairless mice.
    Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:1

    Topics: Aminolevulinic Acid; Animals; Calcitriol; Dermatologic Agents; Female; Mice; Mice, Nude; Photosensitizing Agents; Protoporphyrins; Skin

2015
Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2015, Volume: 14, Issue:5

    Topics: Adult; Aminolevulinic Acid; Erythema; Fluorescence; Forearm; Humans; Inflammation; Male; Middle Aged; Pain; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Pigmentation; Time Factors; White People; Young Adult

2015
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
    Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 154

    Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays

2016
Short-term chemical pretreatment cannot replace curettage in photodynamic therapy.
    Photodermatology, photoimmunology & photomedicine, 2016, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Curettage; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorescence; Healthy Volunteers; Humans; Keratolytic Agents; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Salicylic Acid; Young Adult

2016
Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration.
    Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 159

    Topics: Adolescent; Adult; Aminolevulinic Acid; Humans; Lasers; Male; Photosensitizing Agents; Protoporphyrins; Spectrometry, Fluorescence; Young Adult

2016
The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
    Redox biology, 2016, Volume: 9

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Histidine; Humans; Iron Chelating Agents; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Pyridones; Reactive Oxygen Species

2016
A consensus on the use of daylight photodynamic therapy in the UK.
    The Journal of dermatological treatment, 2017, Volume: 28, Issue:4

    Topics: Aminolevulinic Acid; Consensus; Humans; Keratosis, Actinic; Light; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; United Kingdom

2017
Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
    Photodiagnosis and photodynamic therapy, 2017, Volume: 17

    Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin Absorption; Sunscreening Agents

2017
Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.
    PloS one, 2018, Volume: 13, Issue:5

    Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Cell Line; Computer Systems; Female; Heterografts; Humans; Mice; Protoporphyrins; Spectrometry, Fluorescence; Squamous Intraepithelial Lesions of the Cervix; Tissue Distribution; Vulvar Neoplasms

2018
Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate.
    International journal of molecular sciences, 2019, Mar-11, Volume: 20, Issue:5

    Topics: Aminolevulinic Acid; Biomarkers; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; HeLa Cells; Humans; Microtubules; Mitosis; Photochemotherapy; Photosensitizing Agents; Protein Transport; Protoporphyrins; Spindle Apparatus

2019
Daylight PDT acts by continuous activation of PpIX.
    Photodiagnosis and photodynamic therapy, 2019, Volume: 27

    Topics: Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Sunlight; Time Factors

2019
Temperature effect on the PpIX production during the use of topical precursors.
    Photodiagnosis and photodynamic therapy, 2020, Volume: 30

    Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats; Rats, Wistar; Temperature

2020
Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.
    International journal of molecular sciences, 2020, May-08, Volume: 21, Issue:9

    Topics: Aminolevulinic Acid; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Ferrochelatase; Heat-Shock Proteins; Humans; Membrane Transport Proteins; Molecular Chaperones; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Species; Skin Neoplasms; Stress, Physiological; Superoxide Dismutase; Survivin; Symporters

2020
MAL-associated methyl nicotinate for topical PDT improvement.
    Journal of photochemistry and photobiology. B, Biology, 2020, Volume: 213

    Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cell Line; Cell Survival; Humans; Male; NAD; Nicotinic Acids; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats, Wistar; Skin; Skin Diseases

2020